Tata Steel and Sensory Analytics, the developer of patented SpecMetrix coating and film thickness measurement systems, have agreed on a global partnership to optimize product performance and coil quality. The industry leaders will team on plant quality enhancements as well as brand and business development initiatives. - July 07, 2021 - Sensory Analytics (SpecMetrix Systems)
HitPath is thrilled to welcome Shaun Hall as the new VP of Sales. As a long time industry insider and an absolute sales fanatic, Shaun brings his experience in affiliate marketing from both the publisher side as well as the advertiser/network side. He will no doubt be a terrific addition to the. - July 07, 2021 - Webapps LLC
Global COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Medical Device Pipeline Market Assessment 2020-2021 Featuring Over 120 Companies
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Global COVID-19 Enzyme Immuno Assay/Enzyme Linked Immunosorbent Assay (EIA/ELISA) Medical Device Pipeline Market Assessment 2020-2021 Featuring Over 120 Companies
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.
Phase One Development of Rapid COVID-19 Point of Care Test Complete
Pepex Biomedical has effectively concluded first stage development efforts including successfully demonstrating working chemistry and manufacturing functionality of its existing electrochemical biosensor. Atlanta, GA, February 11, 2021 (PR.com) Pepex Biomedical, Inc. (the “Company”), a leading developer of enzymatic biosensor technology, has completed the initial development phase of its forthcoming suite of immunosensor testing products designed to accurately identify COVID-19 antigens and antibodies in under 15 minutes with 95% accuracy.
The scope of the project includes at least four self-administered devices that include two saliva-based sensors; one that will detect the presence of the COVID-19 virus in less than 15 minutes at a greater than 95% accuracy, and a second sensor device with the ability to quantify the viral load. The other two devices use Pepex novel sensor technology to detect antibodies